n-valyltryptophan has been researched along with hispidulin in 1 studies
| Studies (n-valyltryptophan) | Trials (n-valyltryptophan) | Recent Studies (post-2010) (n-valyltryptophan) | Studies (hispidulin) | Trials (hispidulin) | Recent Studies (post-2010) (hispidulin) |
|---|---|---|---|---|---|
| 13 | 0 | 6 | 123 | 0 | 76 |
| Protein | Taxonomy | n-valyltryptophan (IC50) | hispidulin (IC50) |
|---|---|---|---|
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 0.8337 | |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | 2.71 | |
| Dipeptidyl peptidase 4 | Sus scrofa (pig) | 0.49 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.3533 | |
| MAP kinase-interacting serine/threonine-protein kinase 1 | Homo sapiens (human) | 1.205 | |
| MAP kinase-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | 0.252 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, CL; Guo, SJ; Jiang, B; Li, N; Li, XQ; Shi, DY; Wang, LJ | 1 |
1 review(s) available for n-valyltryptophan and hispidulin
| Article | Year |
|---|---|
Recent progress of the development of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Structure-Activity Relationship | 2018 |